L. rhamnosus HA-114 is an innovative patent-pending probiotic strain able to improve eating and mood-related behaviors in overweight adults undergoing a diet-induced weight loss. It could favor wellness and facilitate adherence during a diet-based weight reduction program, through its action on the brain-gut axis. L. rhamnosus HA-114 supports weight management efforts during a diet (eating […]
Lacticaseibacillus rhamnosus HA-114 Read More »
Several studies have shown that Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) can survive and persist in the gastrointestinal tract in humans. The strain was even recovered in the faeces in nearly all subjects up to 15 days after administration. Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) has been shown to support the immune system, as well
Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) Read More »
Lacticaseibacillus paracasei LPC1114 (DSM 34559), developed by SynBalance.Gastrointestinal Health • Oral Health
Lacticaseibacillus paracasei LPC1114 (DSM 34559) Read More »
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
